Anticipate That Brexanolone Will Be Saved for Severe Postpartum Depression

May 2019

Brexanolone (Zulresso, zul-REH-soh) will be a new injectable med for treating postpartum depression.

Women with postpartum depression often get SSRIs (sertraline, etc)...which take a week or more to start working. Brexanolone's effects kick in sooner...within 24 to 48 hours.

But expect brexanolone to be saved for severe cases. It costs up to $34,000/course...and it can cause serious side effects, such as sedation and loss of consciousness.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Safety Optimize the Appearance of Med Warnings to Help Them Get Noticed
Certification Watch for Changes to Pharmacy Tech Certification and Credentialing
Medication Errors Stop Errors Between Dexamethasone and Dexmedetomidine in Their Tracks
Women's Health Anticipate That Brexanolone Will Be Saved for Severe Postpartum Depression
Transitions of Care Catch Common Med Mishaps in Patients Transferring Out of ICU
Depression Find Out if Your Hospital Will Administer Spravato for Depression
Pumps Help Prevent Issues When a Patient With an Intrathecal Pump Is Admitted
Parkinson's Disease Inbrija Will Be an Inhaled "On Demand" Med for Parkinson's Disease
Ophthalmology Look for the New Rx Eye Drop Cequa for Dry Eyes
ADHD Expect to Hear About Psychosis With ADHD Stimulants

Anticipate That Brexanolone Will Be Saved for Severe Postpartum Depression

Practical advice for a better career, with unlimited access to CE

Table of Contents